StockMarketWire.com - Braveheart Investment Group has announced that it has agreed terms to sell its interest in Biopta to ReproCELL, a Japanese listed company.
The total consideration is to be satisfied as to approximately 50% in cash and 50% in ReproCELL shares.
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.